These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8267738)

  • 21. Lick your lips: a case of salivary contamination after I-131 therapy for thyroid carcinoma.
    Roman MR; Larcos G; Devadas M
    Clin Nucl Med; 2002 Jun; 27(6):462. PubMed ID: 12045452
    [No Abstract]   [Full Text] [Related]  

  • 22. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
    Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal thymic uptake of 2-deoxy-2[F-18]fluoro-D-glucose.
    Alibazoglu H; Alibazoglu B; Hollinger EF; Ingram SA; Willoughby WA; LaMonica G; Ali A
    Clin Nucl Med; 1999 Aug; 24(8):597-600. PubMed ID: 10439182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High radioactive iodine uptake despite a fully suppressed TSH in a patient with thyroid cancer.
    Stathatos N; Gaz R; Ross DS; Daniels GH
    J Clin Endocrinol Metab; 2011 Mar; 96(3):589. PubMed ID: 21378221
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymus accumulation of I-131 after therapeutic dose for thyroid carcinoma.
    Muratet JP; Giraud P
    Clin Nucl Med; 1996 Sep; 21(9):736-7. PubMed ID: 8879880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation].
    Liu RT; Huang MJ; Huang HS; Huang BY; Lin JD; Wang PW; Tzen KY
    Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):524-8. PubMed ID: 3625158
    [No Abstract]   [Full Text] [Related]  

  • 28. Iodine-131 whole-body scan for post-surgical follow-up of differentiated thyroid carcinoma.
    Degrossi OJ; García del Río H; Degrossi EB
    J Nucl Med; 1991 Sep; 32(9):1826. PubMed ID: 1880588
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical significance of diffuse hepatic visualization and thyroid bed uptake on post-ablative iodine-131 whole body scan in differentiated thyroid cancer.
    Kim K; Kim SJ; Kim IJ; Kim YK; Kim BS; Pak K
    Onkologie; 2012; 35(3):82-6. PubMed ID: 22414970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
    Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
    J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
    Schraube P; Kimmig B; zum Winkel K
    Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irradiating the thyroid. How to protect yourself and others.
    Jankowski CB
    Am J Nurs; 1996 Oct; 96(10):50-4. PubMed ID: 8863650
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
    Leung SF; Law MW; Ho SK
    Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer].
    García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C
    Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
    Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
    Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [131 iodine for the initial treatment of thyroid cancer].
    Delisle MJ; Clerc J
    Ann Endocrinol (Paris); 1997; 58(3):197-203. PubMed ID: 9239241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iodine-131 in breast milk following therapy for thyroid carcinoma.
    Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
    J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma.
    Haveman JW; Phan HT; Links TP; Jager PL; Plukker JT
    Cancer; 2005 Jan; 103(1):59-67. PubMed ID: 15565567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of thyroid carcinoma with radioactive 131I.
    Paryani SB; Chobe RJ; Scott W; Wells J; Johnson D; Kuruvilla A; Schoeppel S; Deshmukh A; Miller R; Dajani L; Montgomery CT; Puestow E; Purcell J; Roura M; Sutton D; Mallett R; Peer J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):83-6. PubMed ID: 8823262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.